PEA3 activates CXCR4 transcription in MDA-MB-231 and MCF7 breast cancer cells
Shengmei Gu1, Li Chen, Qi Hong
1Department of Breast Surgery, Breast Cancer Institute, Department of Oncology, Shanghai Medical College, Institute of Biomedical Science, Fudan University, China.
Abstract:
CXC chemokine receptor 4 (CXCR4) is a cell surface receptor that has been shown to mediate the metastasis of many solid tumors including lung, breast, kidney, and prostate tumors. In this study, we found that overexpression of ets variant gene 4 (PEA3) could elevate CXCR4 mRNA level and CXCR4 promoter activity in human MDA-MB-231 and MCF-7 breast cancer cells. PEA3 promoted CXCR4 expression and breast cancer metastasis. Chromatin immunoprecipitation assay demonstrated that PEA3 could bind to the CXCR4 promoter in the cells transfected with PEA3 expression vector. PEA3 siRNA attenuated CXCR4 promoter activity and the binding of PEA3 to the CXCR4 promoter in MDA-MB-231 and MCF-7 cells. These results indicated that PEA3 could activate CXCR4 promoter transcription and promote breast cancer metastasis.
Insights
Overexpression of ets variant gene 4 (PEA3) boosts CXC chemokine receptor 4 (CXCR4) levels, driving breast cancer metastasis. PEA3 directly activates the CXCR4 promoter, highlighting a key mechanism in cancer spread.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- CXC chemokine receptor 4 (CXCR4) is implicated in the metastasis of various solid tumors.
- Understanding the regulatory mechanisms of CXCR4 is crucial for developing anti-metastatic therapies.
Purpose of the Study:
- To investigate the role of ets variant gene 4 (PEA3) in regulating CXCR4 expression and promoting breast cancer metastasis.
- To elucidate the molecular mechanism by which PEA3 influences CXCR4 activity.
Main Methods:
- Overexpression and siRNA-mediated knockdown of PEA3 in human breast cancer cell lines (MDA-MB-231 and MCF-7).
- Quantitative analysis of CXCR4 mRNA levels and promoter activity.
- Chromatin immunoprecipitation (ChIP) assays to assess PEA3 binding to the CXCR4 promoter.
Main Results:
- Overexpression of PEA3 significantly increased CXCR4 mRNA levels and promoter activity in breast cancer cells.
- PEA3 was demonstrated to bind directly to the CXCR4 promoter region.
- PEA3 knockdown using siRNA reduced CXCR4 promoter activity and PEA3-CXCR4 promoter binding.
- PEA3 overexpression correlated with enhanced breast cancer cell metastasis.
Conclusions:
- PEA3 acts as a transcriptional activator of the CXCR4 gene.
- PEA3 promotes breast cancer metastasis, at least in part, by upregulating CXCR4 expression.
- Targeting the PEA3-CXCR4 axis may represent a therapeutic strategy for inhibiting breast cancer metastasis.
Related Concept Videos
Master Transcription Regulators
MAPK Signaling Cascades
Cell Specific Gene Expression
Mitogens and the Cell Cycle
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...


